Skip to main content
Erschienen in: Lung 1/2020

26.11.2019 | LUNG CANCER

Lung Cancer in the Young

verfasst von: Marco Galvez-Nino, Rossana Ruiz, Joseph A. Pinto, Katia Roque, Raul Mantilla, Luis E. Raez, Luis Mas

Erschienen in: Lung | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Median age at diagnosis of lung cancer is 70 years. Its presentation in patients 40 or younger is uncommon and it has been proposed that maybe it is a different disease due to its clinical characteristics and genetic makeup. There are a limited number of studies in this population and they report different clinic-pathological characteristics in comparison with older patients.

Methods

We described the incidence of lung cancer patients diagnosed at age 40 or younger at the Instituto Nacional de Enfermedades Neoplasicas (INEN), Lima-Peru; from 2009 to 2017 and evaluated the characteristic of NSCLC. Epidemiologic and clinic-pathological data was collected from clinical files. Analysis was carried out using SPSSvs19 software.

Results

We identified 3823 patients with lung cancer seen at INEN during the study period. Among these, 166 (4.3%) patients were 40 years or younger, and 137/166 (82.5%) were NSCLC. Median age at diagnosis was 36 years (range 14–40 years) and 59.1% of patients were female. A smoking history was present in 14.4% of patients. Frequent symptoms at diagnosis were cough (62.0%), chest pain (51.8%) and dyspnea (40.9%). Adenocarcinoma was the most common histological type (63.3%). Most patients had advanced disease at diagnosis (84.7%). The median overall survival was 8.2 months.

Conclusions

The proportion of young patients with lung cancer in our population is higher than that reported in the most recent literature. Lung cancer in the young is mostly sporadic, more frequent in women, usually adenocarcinoma type and it presents with advanced disease, resulting in a very poor survival.
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30CrossRef Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30CrossRef
2.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386CrossRef
3.
Zurück zum Zitat Cerfolio RJ, Bryant AS (2006) Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: a nested case-control study. Ann Thorac Surg 82:424–430CrossRef Cerfolio RJ, Bryant AS (2006) Survival and outcomes of pulmonary resection for non-small cell lung cancer in the elderly: a nested case-control study. Ann Thorac Surg 82:424–430CrossRef
4.
Zurück zum Zitat Thomas A, Chen Y, Yu T, Jakopovic M, Giaccone G (2015) Trends and characteristics of young non-small cell lung cancer patients in the United States. Front Oncol 5:113CrossRef Thomas A, Chen Y, Yu T, Jakopovic M, Giaccone G (2015) Trends and characteristics of young non-small cell lung cancer patients in the United States. Front Oncol 5:113CrossRef
5.
Zurück zum Zitat Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J et al (2010) Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis. J Thorac Oncol 5:23–28CrossRef Subramanian J, Morgensztern D, Goodgame B, Baggstrom MQ, Gao F, Piccirillo J et al (2010) Distinctive characteristics of non-small cell lung cancer (NSCLC) in the young: a surveillance, epidemiology, and end results (SEER) analysis. J Thorac Oncol 5:23–28CrossRef
6.
Zurück zum Zitat Maruyama R, Yoshino I, Yohena T, Uehara T, Kanematsu T, Kitajima M et al (2001) Lung cancer in patients younger than 40 years of age. J Surg Oncol 77:208–212CrossRef Maruyama R, Yoshino I, Yohena T, Uehara T, Kanematsu T, Kitajima M et al (2001) Lung cancer in patients younger than 40 years of age. J Surg Oncol 77:208–212CrossRef
7.
Zurück zum Zitat Li J, Yang F, Li X, Zhang M, Fu R, Yin X et al (2015) Characteristics, survival, and risk factors of Chinese young lung cancer patients: the experience from two institutions. Oncotarget 8:89236–89244 Li J, Yang F, Li X, Zhang M, Fu R, Yin X et al (2015) Characteristics, survival, and risk factors of Chinese young lung cancer patients: the experience from two institutions. Oncotarget 8:89236–89244
8.
Zurück zum Zitat Sacher AG, Dahlberg SE, Heng J, Mach S, Jänne PA, Oxnard GR (2016) Association between younger age and targetable genomic alterations and prognosis in non-small-cell lung cancer. JAMA Oncol 2:313–320CrossRef Sacher AG, Dahlberg SE, Heng J, Mach S, Jänne PA, Oxnard GR (2016) Association between younger age and targetable genomic alterations and prognosis in non-small-cell lung cancer. JAMA Oncol 2:313–320CrossRef
12.
Zurück zum Zitat Thun MJ, Jemal A (2006) How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control 15:345–347CrossRef Thun MJ, Jemal A (2006) How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control 15:345–347CrossRef
14.
Zurück zum Zitat Cheng T-YD, Cramb SM, Baade PD, Youlden DR, Nwogu C, Reid ME (2016) The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics. J Thorac Oncol 11:1653–1671CrossRef Cheng T-YD, Cramb SM, Baade PD, Youlden DR, Nwogu C, Reid ME (2016) The international epidemiology of lung cancer: latest trends, disparities, and tumor characteristics. J Thorac Oncol 11:1653–1671CrossRef
16.
Zurück zum Zitat Vidaurre T, Santos C, Gómez H, Sarria G, Amorin E, López M et al (2017) The implementation of the Plan Esperanza and response to the imPACT Review. Lancet Oncol 18:e595–e606CrossRef Vidaurre T, Santos C, Gómez H, Sarria G, Amorin E, López M et al (2017) The implementation of the Plan Esperanza and response to the imPACT Review. Lancet Oncol 18:e595–e606CrossRef
17.
Zurück zum Zitat Nevin PE, Garcia PJ, Blas MM, Rao D, Molina Y (2019) Inequities in cervical cancer care in indigenous Peruvian women. Lancet Glob Health 7:e556–e557CrossRef Nevin PE, Garcia PJ, Blas MM, Rao D, Molina Y (2019) Inequities in cervical cancer care in indigenous Peruvian women. Lancet Glob Health 7:e556–e557CrossRef
18.
Zurück zum Zitat Wang T, Ren H, Li Z, Zhang Z, Sun C, Xu L (1993) Misdiagnosis of lung cancer in patients under age 40—a clinical analysis of 47 cases. Chinese Med Sci J = Chung-kuo i hsueh k’o hsueh tsa chih 8:95–97 Wang T, Ren H, Li Z, Zhang Z, Sun C, Xu L (1993) Misdiagnosis of lung cancer in patients under age 40—a clinical analysis of 47 cases. Chinese Med Sci J = Chung-kuo i hsueh k’o hsueh tsa chih 8:95–97
19.
Zurück zum Zitat Walter FM, Rubin G, Bankhead C, Morris HC, Hall N, Mills K et al (2015) Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. Br J Cancer 112:S6–S13CrossRef Walter FM, Rubin G, Bankhead C, Morris HC, Hall N, Mills K et al (2015) Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. Br J Cancer 112:S6–S13CrossRef
20.
Zurück zum Zitat Igata F, Uchino J, Fujita M, Iwasaki A, Watanabe K (2016) Clinical features of lung cancer in japanese patients aged under 50. Asian Pac J Cancer Prev 17:3377–3380PubMed Igata F, Uchino J, Fujita M, Iwasaki A, Watanabe K (2016) Clinical features of lung cancer in japanese patients aged under 50. Asian Pac J Cancer Prev 17:3377–3380PubMed
21.
Zurück zum Zitat Birring SS, Peake MD (2005) Symptoms and the early diagnosis of lung cancer. Thorax 60:268–269CrossRef Birring SS, Peake MD (2005) Symptoms and the early diagnosis of lung cancer. Thorax 60:268–269CrossRef
22.
Zurück zum Zitat Lienert T, Serke M, Scho N, Nfeld È, Loddenkemper R (2000) Lung cancer in young females. Eur Respir J 16:986–990CrossRef Lienert T, Serke M, Scho N, Nfeld È, Loddenkemper R (2000) Lung cancer in young females. Eur Respir J 16:986–990CrossRef
23.
Zurück zum Zitat Ruiz R, Galvez Nino M, Roque Perez K, Moreno J, Valdivieso N, Olivera M et al (2019) Epidemiology of advanced lung cancer in Peru. Abstr B 20th World Conference on Lung Cancer. Barcelona, Spain, p 915 Ruiz R, Galvez Nino M, Roque Perez K, Moreno J, Valdivieso N, Olivera M et al (2019) Epidemiology of advanced lung cancer in Peru. Abstr B 20th World Conference on Lung Cancer. Barcelona, Spain, p 915
24.
Zurück zum Zitat Champagne BM, Sebrié EM, Schargrodsky H, Pramparo P, Boissonnet C, Wilson E (2010) Tobacco smoking in seven Latin American cities: the CARMELA study. Tob Control 19:457–462CrossRef Champagne BM, Sebrié EM, Schargrodsky H, Pramparo P, Boissonnet C, Wilson E (2010) Tobacco smoking in seven Latin American cities: the CARMELA study. Tob Control 19:457–462CrossRef
25.
Zurück zum Zitat Morgan BW, Leifheit KM, Romero KM, Gilman RH, Bernabe-Ortiz A, Miranda JJ et al (2017) Low cigarette smoking prevalence in peri-urban Peru: results from a population-based study of tobacco use by self-report and urine cotinine. Tob Induc Dis. 15:32 Morgan BW, Leifheit KM, Romero KM, Gilman RH, Bernabe-Ortiz A, Miranda JJ et al (2017) Low cigarette smoking prevalence in peri-urban Peru: results from a population-based study of tobacco use by self-report and urine cotinine. Tob Induc Dis. 15:32
26.
Zurück zum Zitat Shen H, Tao S, Liu J, Huang Y, Chen H, Li W et al (2015) Global lung cancer risk from PAH exposure highly depends on emission sources and individual susceptibility. Sci Rep 4:6561CrossRef Shen H, Tao S, Liu J, Huang Y, Chen H, Li W et al (2015) Global lung cancer risk from PAH exposure highly depends on emission sources and individual susceptibility. Sci Rep 4:6561CrossRef
27.
Zurück zum Zitat Dilger M, Orasche J, Zimmermann R, Paur H-R, Diabaté S, Weiss C (2016) Toxicity of wood smoke particles in human A549 lung epithelial cells: the role of PAHs, soot and zinc. Arch Toxicol 90:3029–3044CrossRef Dilger M, Orasche J, Zimmermann R, Paur H-R, Diabaté S, Weiss C (2016) Toxicity of wood smoke particles in human A549 lung epithelial cells: the role of PAHs, soot and zinc. Arch Toxicol 90:3029–3044CrossRef
28.
Zurück zum Zitat Raspanti GA, Hashibe M, Siwakoti B, Wei M, Thakur BK, Pun CB et al (2016) Household air pollution and lung cancer risk among never-smokers in Nepal. Environ Res 147:141–145CrossRef Raspanti GA, Hashibe M, Siwakoti B, Wei M, Thakur BK, Pun CB et al (2016) Household air pollution and lung cancer risk among never-smokers in Nepal. Environ Res 147:141–145CrossRef
29.
Zurück zum Zitat Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers—a different disease. Nat Rev Cancer 7:778–790CrossRef Sun S, Schiller JH, Gazdar AF (2007) Lung cancer in never smokers—a different disease. Nat Rev Cancer 7:778–790CrossRef
30.
Zurück zum Zitat Korpanty GJ, Kamel-Reid S, Pintilie M, Hwang DM, Zer A, Liu G et al (2018) Lung cancer in never smokers from the Princess Margaret Cancer Centre. Oncotarget 9:22559–22570CrossRef Korpanty GJ, Kamel-Reid S, Pintilie M, Hwang DM, Zer A, Liu G et al (2018) Lung cancer in never smokers from the Princess Margaret Cancer Centre. Oncotarget 9:22559–22570CrossRef
31.
Zurück zum Zitat Pan X, Lv T, Zhang F, Fan H, Liu H, Song Y (2018) Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or younger. Clin Transl Oncol 20:1168–1174CrossRef Pan X, Lv T, Zhang F, Fan H, Liu H, Song Y (2018) Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or younger. Clin Transl Oncol 20:1168–1174CrossRef
36.
Zurück zum Zitat Brennan P, Hainaut P, Boffetta P (2011) Genetics of lung-cancer susceptibility. Lancet Oncol 12:399–408CrossRef Brennan P, Hainaut P, Boffetta P (2011) Genetics of lung-cancer susceptibility. Lancet Oncol 12:399–408CrossRef
37.
Zurück zum Zitat Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, Jonsson HH, Kristjansson K, Arnason S et al (2004) Familial risk of lung carcinoma in the icelandic population. JAMA 292:2977CrossRef Jonsson S, Thorsteinsdottir U, Gudbjartsson DF, Jonsson HH, Kristjansson K, Arnason S et al (2004) Familial risk of lung carcinoma in the icelandic population. JAMA 292:2977CrossRef
38.
Zurück zum Zitat Zhang Y, Shu X-O, Gao Y-T, Ji B-T, Yang G, Li HL et al (2007) Family history of cancer and risk of lung cancer among nonsmoking Chinese women. Cancer Epidemiol Biomarkers Prev 16:2432–2435CrossRef Zhang Y, Shu X-O, Gao Y-T, Ji B-T, Yang G, Li HL et al (2007) Family history of cancer and risk of lung cancer among nonsmoking Chinese women. Cancer Epidemiol Biomarkers Prev 16:2432–2435CrossRef
39.
Zurück zum Zitat Bryant AS, Cerfolio RJ (2008) Differences in outcomes between younger and older patients with non-small cell lung cancer. Ann Thorac Surg 85:1735–1739CrossRef Bryant AS, Cerfolio RJ (2008) Differences in outcomes between younger and older patients with non-small cell lung cancer. Ann Thorac Surg 85:1735–1739CrossRef
40.
Zurück zum Zitat Arnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ et al (2016) Lung cancer in the very young: treatment and survival in the national cancer data base. J Thorac Oncol 11:1121–1131CrossRef Arnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ et al (2016) Lung cancer in the very young: treatment and survival in the national cancer data base. J Thorac Oncol 11:1121–1131CrossRef
41.
Zurück zum Zitat Jiang W, Kang Y, Shi G-Y, Zhang H-Y, Cai L, Sun X-W et al (2012) Comparisons of multiple characteristics between young and old lung cancer patients. Chin Med J (Engl) 125:72–80 Jiang W, Kang Y, Shi G-Y, Zhang H-Y, Cai L, Sun X-W et al (2012) Comparisons of multiple characteristics between young and old lung cancer patients. Chin Med J (Engl) 125:72–80
42.
Zurück zum Zitat Cherny NI, Sullivan R, Torode J, Saar M, Eniu A (2017) ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe. Ann Oncol 28:2633–2647CrossRef Cherny NI, Sullivan R, Torode J, Saar M, Eniu A (2017) ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe. Ann Oncol 28:2633–2647CrossRef
Metadaten
Titel
Lung Cancer in the Young
verfasst von
Marco Galvez-Nino
Rossana Ruiz
Joseph A. Pinto
Katia Roque
Raul Mantilla
Luis E. Raez
Luis Mas
Publikationsdatum
26.11.2019
Verlag
Springer US
Erschienen in
Lung / Ausgabe 1/2020
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-019-00294-5

Weitere Artikel der Ausgabe 1/2020

Lung 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.